U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Oncology Center of Excellence
  1. FDA Organization

Oncology Center of Excellence

2023 Mission Vision OCE Graphic

Connect With Us!

Twitter: FDAOncology • Email: [email protected]

The Oncology Center of Excellence (OCE) was authorized by the 21st Century Cures Act of 2016 and established on January 19, 2017. The Center unites experts across the FDA to conduct expedited review of medical products for oncologic and hematologic malignancies. The OCE also leads a variety of research and educational outreach projects and programs to advance the development and regulation of medical products for patients with cancer.

To learn more about the Oncology Center of Excellence, read the OCE Director's Message.



Featured Projects and Events

Box 2

Project Confirm

Project Confirm is an initiative of the FDA Oncology Center of Excellence to promote the transparency of outcomes related to Accelerated Approvals for oncology indications.
Box 2

Project Orbis

Project Orbis provides a framework for concurrent submission and review of oncology products among international regulators, which may allow patients with cancer to receive earlier access to products.
Box 2

Project Optimus

Is an initiative to reform the dose optimization and dose selection paradigm in oncology drug development.
Box 4

OCE Summer Scholars

The FDA OCE Summer Scholars Program is designed to introduce high school students with an interest in STEM (science, technology, engineering, or mathematics) to the cancer drug development process.



Back to Top